Abstract:Abstract Background Growth factors (GFs) are signaling proteins that affect cellular processes such as growth, proliferation, and differentiation. GFs are used as cosmeceuticals, exerting anti-wrinkle, anti-aging, and whitening effects, and also as pharmaceuticals to treat wounds, growth failure, and oral mucositis. However, in mammalian and bacterial cells, low productivity and expression in inclusion bodies, respectively, of GFs does not satisfy the consumer demand. Here, we aimed to develop a bacterial expression system that produces high yields of soluble GFs that can be purified in their native forms. Results We present Fh8, an 8-kDa peptide from Fasciola hepatica with an N-terminal hexa-histidine (6HFh8), as a fusion partner for enhanced human GF production in recombinant Escherichia coli . The fusion partner harboring a tobacco etch virus (TEV) protease cleavage site was fused to the N-terminus of 10 human GFs: acidic and basic fibroblast growth factors (aFGF and bFGF, respectively), epidermal growth factor (EGF), human growth hormone (hGH), insulin-like growth factor 1 (IGF-1), vascular endothelial growth factor 165 (VEGF165), keratinocyte growth factor 1 (KGF-1), placental growth factor (PGF), stem cell factor (SCF), and tissue inhibitor of metalloproteinase 1 (TIMP-1). The fusion proteins were expressed in E. coli under the control of T7 promoter at three temperatures (25 °C, 30 °C, and 37 °C). All individual fusion proteins, except for SCF and TIMP-1, were successfully overexpressed in cytoplasmic soluble form at more than one temperature. Further, the original aFGF, IGF-1, EGF, and VEGF165 proteins were cleaved from the fusion partner by TEV protease. Five-liter fed-batch fermentation approaches for the 6HFh8-aFGF (lacking disulfide bonds) and 6HFh8-VEGF165 (a cysteine-rich protein) were devised to obtain the target protein at concentrations of 9.7 g/l and 3.4 g/l, respectively. The two GFs were successfully highly purified (> 99% purity). Furthermore, they exerted similar cell proliferative effects as those of their commercial equivalents. Conclusions We demonstrated that 6HFh8-GF fusion proteins could be overexpressed on a g/l scale in the cytoplasm of E. coli , with the GFs subsequently highly purified and maintaining their biological activity. Hence, the small protein 6HFh8 can be used for efficient mass-production of various GFs.

[Hypercalcemia and multiple osteolytic lesions associated with proinflammatory cytokines in a patient with acute lymphoblastic leukemia].

Renal cell carcinoma and acquired cystic kidney disease after renal transplantation

Recombinant human epidermal growth factor inclusion body solubilization and refolding at large scale using expanded-bed adsorption chromatography from Escherichia coli

Optimization of the Fermentation Conditions of Pep-1-Fused EGF in Escherichia coli

Economic optimization of expression of soluble human epidermal growth factor in Escherichia coli

Cloning, Expression, and Cost Effective Purification of Authentic Human Epidermal Growth Factor With High Activity

High-Level Soluble Expression of Higf-1 Fusion Protein in Recombinant Escherichia Coli

[Enhancing the Expression Level of Human Epidermal Growth Factor Using the Polyhedrin Protein Sequence of BmNPV].

Effective production of human growth factors in Escherichia coli by fusing with small protein 6HFh8

Assessing the performance of density functional theory for the electronic structure of metal-salens: the 3d(0)-metals.

[Temporomandibular joint status of old collum fractures with occlusal disorders before and after grinding therapy].

Refolding and Purification of Recombined Human Endostatin Using Cation Exchange Chromatography

Overexpression and Purification of Recombinant Atrial Natriuretic Peptide Using Hybrid Fusion Protein REF-ANP in Escherichia Coli

Efficient Soluble Expression and Purification of Recombinant Human Acidic Fibroblast Growth Factor from Escherichia coli via Fusion with a Novel Collagen-like Protein Scl2

A novel two-stage continuous process for excretive expression of hEGF by recombinant E. coli JM101

The Expression of Recombinant Human Hepatocyte Growth Factor in Pichia pastoris

Efficient Soluble Expression and Purification of Recombinant Human Acidic Fibroblast Growth Factor Fromescherichia Colivia Fusion with a Novel Collagen-like Protein Scl2

Cracking the ENCODE: From transcription to therapeutics

Purification and Refolding Escherichia Coli Produced Enterokinase Inclusion Bodies Immobilized by Nickel Chelating Chromatography

Purification of inclusion bodies using PEG precipitation under denaturing conditions to produce recombinant therapeutic proteins from Escherichia coli

Separation And Purification Of Escherichia Coli-Ex Pressed Human Thymosin-Alpha 1 Using Affinity Chromatography And High-Performance Liquid Chromatography